http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74b2d1d87132bfdf3ecaca872b985c5f
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Miron |
| name | Alexander Miron |
| given-name | Alexander |
| organization-name | Authors' Affiliations: 1Cancer Prevention Institute of California, Fremont; 2Division of Epidemiology, Department of Health Research and Policy, 3Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford; 4Department of Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles, California; 5Fred A. Litwin Centre for Cancer Genetics, 6Prosserman Centre for Health Research, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; 7Department of Laboratory Medicine and Pathobiology, 8Department of Molecular Genetics, 9Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; 10Genetic & Molecular Epidemiology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain; 11Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, 12Department of Pathology, The University of Melbourne; 13Cancer Epidemiology Centre, Cancer Council Victoria; 14Peter MacCallum Cancer Centre, Melbourne, Victoria, 6Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA, Allison W. Kurian, Gail D. Gong, Esther M. John, David A. Johnston, Anna Felberg, Dee W. West, and Alice S. Whittemore, Stanford University School of Medicine, Stanford; Esther M. John and Dee W. West, Cancer Prevention Institute of California, Fremont, CA; Alexander Miron, Dana-Farber Cancer Institute, Boston, MA; Irene L. Andrulis, Julia A. Knight, and Hilmi Ozcelik, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Irene L. Andrulis and Hilmi Ozcelik, University of Toronto; Irene L. Andrulis,... Case Comprehensive Cancer Center Case Western Reserve University Cleveland Ohio USA; Department of Genetics and Genomics Case Western Reserve University Cleveland Ohio USA 10Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Genetics, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710 3Department of Cell Biology, Harvard Medical School; Departments of 5Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts Authors' Affiliations: Departments of 1Cancer Biology, 2Medical Oncology, and 3Biostatistic and Computational Biology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 5Harvard Medical School, 6Department of Pathology, Brigham and Women's Hospital, 7Harvard School of Public Health, Boston, Massachusetts; 8Department of Pathology, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Gyeonggi, South Korea; 9Department of Pathology, Samsung Medical Center, Seoul, South Korea; and 10Department of Pathology, Washington University School of Medicine, St. Louis, Missouri; Authors' Affiliations: Departments of 1Cancer Biology, 2Medical Oncology, and 3Biostatistic and Computational Biology, and 4Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, 5Harvard Medical School, 6Department of Pathology, Brigham and Women's Hospital, 7Harvard School of Public Health, Boston, Massachusetts; 8Department of Pathology, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Gyeonggi, South Korea; 9Department of Pathology, Samsung Medical Center, Seoul, South Korea; and 10Department of Pathology, Washington University School of Medicine, St. Louis, Missouri From the Division of Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School; and Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA Department of Genetics and Genome Sciences, 6Department of Cancer Biology, Dana-Farber Cancer Institute and 4Dana-Farber Cancer Institute, Boston, Massachusetts 4Case Comprehensive Cancer Center, Cleveland, Ohio.; 6Department of Genetics and Genome Science, CWRU School of Medicine, Cleveland, Ohio. Plexseq Diagnostics Cleveland Ohio USA Case Western Reserve University School of Medicine Department of Genetics and Genomic Science, , Cleveland, OH 44106 , USA AgriPlex Genomics Cleveland OH USA; Department of Genetics and Genome Sciences Case Western Reserve University Medical School Cleveland OH USA From the Dana-Farber Cancer Institute; Brigham and Women's Hospital; Children's Hospital Informatics Program at the Harvard–Massachusetts Institute of Technology Division of Health Sciences and Technology; Massachusetts General Hospital Cancer Center; Beth Israel Deaconess Hospital, Harvard Medical School; Harvard School of Public Health, Boston, MA; Center for Biological Sequence Analysis, BioCentrum-Technical University of Denmark, Lyngby, Denmark; Cancer Institute of New Jersey, Robert Wood Johnson... Cancer Biology, Dana–Farber Cancer Institute and Harvard Medical School, Boston, MA 02215; PlexSeq Diagnostics Cleveland OH USA Dana-Farber Cancer Institute, Boston, MA, USA, 1Departments of Surgery and Authors' Affiliations: Departments of 1Cancer Biology, 2Biostatistics and Computational Biology, and 3Medical Oncology, Dana-Farber Cancer Institute; 4Department of Pathology and 5Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts; 6Center for Biological Sequence Analysis, Technical University of Denmark, Lyngby, Denmark; 7Cancer Genomics Program, Departments of 8Biochemistry and 9Pathology, and 10Familial Cancer Centre, Peter MacCallum Cancer Centre and the University of Melbourne, Parkville, Melbourne, Victoria; 11Department of Gynaecological Oncology and Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia; 12Department of Obstetrics and Gynecology, Haukeland University Hospital; and 13Department of Clinical Medicine, University of Bergen, Bergen, Norway Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm Department of Cancer Biology and Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Boston, United States Departments of Cancer Biology and Biostatistics, Dana-Farber Cancer Institute, Boston, Massachusetts, Institute of Proteomics and Systems Biology, Institute of Biomedical Science, Fudan University, Shanghai, People's Republic of China, Department of Family and Preventive Medicine, University of California San Diego, San Diego, California, Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, Program in Computational Biology, Fred Hutchinson Cancer Research Center, Seattle,... Dana-Farber Cancer Institute, Boston, Massachusetts. Authors' Affiliations: 1Center for Functional Cancer Epigenetics; Departments of 2Medical Oncology and 3Cancer Biology, Dana-Farber Cancer Institute; Departments of 4Surgery and 5Pathology, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Department of Surgery, Brigham and Women’s Hospital, Boston, MA 02115, USA. Maren Weischer, Børge G. Nordestgaard, Henrik Flyger, and Stig E. Bojesen, University of Copenhagen, Copenhagen, Denmark; Paul Pharoah, Manjeet K. Bolla, Alison M. Dunning, Qin Wang, Mitul Shah, and Douglas F. Easton, University of Cambridge, Cambridge; Montserrat Garcia-Closas, Institute of Cancer Research, London; Angela Cox, Malcolm W.R. Reed, and Simon S. Cross, University of Sheffield, Sheffield, United Kingdom; Heli Nevanlinna, Taru A. Muranen, and Carl Blomqvist, University of Helsinki and... |
Incoming Links
Total number of triples: 127.